4 research outputs found

    Adaptive Precoded MIMO for LTE Wireless Communication

    No full text
    Long-Term Evolution (LTE) and Long Term Evolution-Advanced (ATE-A) have provided a major step forward in mobile communication capability. The objectives to be achieved are high peak data rates in high spectrum bandwidth and high spectral efficiencies. Technically, pre-coding means that multiple data streams are emitted from the transmit antenna with independent and appropriate weightings such that the link throughput is maximized at the receiver output thus increasing or equalizing the received signal to interference and noise (SINR) across the multiple receiver terminals. However, it is not reliable enough to fully utilize the information transfer rate to fit the condition of channel according to the bandwidth size. Thus, adaptive pre-coding is proposed. It applies pre-coding matrix indicator (PMI) channel state making it possible to change the pre-coding codebook accordingly thus improving the data rate higher than fixed pre-coding

    The Molecular Taxonomy of Primary Prostate Cancer

    Get PDF
    There is substantial heterogeneity among primary prostate cancers, evident in the spectrum of molecular abnormalities and its variable clinical course. As part of The Cancer Genome Atlas (TCGA), we present a comprehensive molecular analysis of 333 primary prostate carcinomas. Our results revealed a molecular taxonomy in which 74% of these tumors fell into one of seven subtypes defined by specific gene fusions (ERG, ETV1/4, and FLI1) or mutations (SPOP, FOXA1, and IDH1). Epigenetic profiles showed substantial heterogeneity, including an IDH1 mutant subset with a methylator phenotype. Androgen receptor (AR) activity varied widely and in a subtype-specific manner, with SPOP and FOXA1 mutant tumors having the highest levels of AR-induced transcripts. 25% of the prostate cancers had a presumed actionable lesion in the PI3K or MAPK signaling pathways, and DNA repair genes were inactivated in 19%. Our analysis reveals molecular heterogeneity among primary prostate cancers, as well as potentially actionable molecular defectsclose
    corecore